26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

heavy chain subclass 314 Helicobacter pylori immunity<br />

in which patients produce excess incomplete α chains of<br />

IgA 1 molecules. It mainly affects Sephardic Jews, Arabs,<br />

and other Mediterranean residents, as well as subjects in<br />

South America and Asia. It may appear in childhood or<br />

adolescence as a lymphoproliferative disorder associated<br />

with the respiratory tract or gastrointestinal tract. Patients<br />

may manifest malabsorption, diarrhea, steatorrhea, hepatic<br />

dysfunction, weight loss, lymphadenopathy, hypocalcemia,<br />

and extensive mononuclear infiltration. α Heavy chain<br />

disease may either spontaneously remit or respond favorably<br />

to treatment with antibiotics; it may require chemotherapy<br />

in some cases. δ Heavy chain disease has been<br />

reported in an elderly male demonstrating abnormal plasma<br />

cell infiltration of the bone marrow along with osteolytic<br />

lesions. γ Heavy chain disease (Franklin’s disease) occurs<br />

in older men, and may induce death rapidly (within weeks)<br />

or last for years. Death usually takes place within 1 year<br />

because of infection. Patients develop lymphoproliferation<br />

with fever, anemia, fatigue, angioimmunoblastic lymphadenopathy,<br />

hepatosplenomegaly, eosinophilic infiltrates,<br />

leukopenia, lymphoma, autoimmune disease, or tuberculosis.<br />

Serum IgG 1 is elevated. γ Heavy chain disease has been<br />

treated with cyclophosphamide, vincristine, and prednisone.<br />

μ Heavy chain disease is a rare condition affecting middleaged<br />

to older individuals. Some patients may ultimately<br />

develop chronic lymphocytic leukemia. μ Heavy chain disease<br />

is characterized by lymphadenopathy, hepatosplenomegaly,<br />

infiltration of the bone marrow by vacuolated plasma<br />

cells, and frequently elevated synthesis of κ light chain.<br />

heavy chain subclass<br />

Within an immunoglobulin heavy chain class, differences<br />

in primary structure associated with the constant region<br />

that can further distinguish these heavy chains of the same<br />

class are designated as subclasses. These differences are<br />

based on primary or antigenic structure. The heavy chain<br />

subclasses are designated γ 1, γ 2, γ 3, etc.<br />

Michael Heidelberger.<br />

Heidelberger, Michael (1888–1991)<br />

An American considered the father of immunochemistry.<br />

He began his career as an organic chemist. His contributions<br />

to immunology include the perfection of quantitative<br />

Michael Heidelberger, who purified the first component of complement<br />

and showed that complement was real, had weight, and contained protein.<br />

immunochemical methods and the immunochemical characterization<br />

of pneumococcal polysaccharides. His contributions<br />

to immunologic research are legion. He received the<br />

Lasker Award, the National Medal of Science, the Behring<br />

Award, the Pasteur Medal, and the French Legion of Honor.<br />

(Refer to Lectures on Immunochemistry, 1956.)<br />

Helicobacter pylori immunity<br />

Both circulating and local humoral antibody responses follow<br />

H. pylori colonization of the gastric mucosa. During the<br />

prolonged mucosal infection, IgG 1 and IgG 4 and often IgG 2<br />

antibodies are detectable but IgG 3 and IgM antibodies only<br />

rarely. IgA antibodies are usually also present. The initial<br />

IgM response is followed later by IgA with conversion to<br />

IgG 22 to 33 days after infection. IgA antibodies are found<br />

at the local mucosal level and are secreted into the gastric<br />

juice. IgG produced locally is rapidly inactivated when it<br />

reaches the gastric juice. A systemic IgG response is present<br />

throughout the infection and diminishes, only prolonging<br />

successful therapy. If the infection reappears, the IgG antibody<br />

titer rises. The specificity of circulating host antibody<br />

against H. pylori varies greatly. This is attributable in part to<br />

variations in host response and to a lesser degree to antigenic<br />

diversity of the microorganisms such as variation in the Vac<br />

A and Cag A proteins. Most infected subjects synthesize<br />

antibodies against numerous antigens, including the urease<br />

subunits, the flagellins, and the 54-kDa HSP60 homolog.<br />

Antibodies usually develop to Vac A and Cag A polypeptides<br />

if they are present in the infecting strain. Although of<br />

variable complexity, the antigens all include urease. Plasma<br />

cells, lymphocytes, and monocytes infiltrate the superficial<br />

layers of the lamina propria in H. pylori-associated gastritis.<br />

Half of the mature B cells and infiltrate are B cells producing<br />

mostly IgA but also IgG and IgM. These cells produce<br />

antibodies specific for H. pylori and are mostly of the CD8 +<br />

subset, although CD4 + T cells are also increased, as well<br />

as γδ T cells. Gastric epithelial cells aberrantly express<br />

HLA-DR during H. pylori infection, which is also associated<br />

with elevated synthesis of IL1, IL6, and TNF-α in the gastric<br />

mucosa. H. pylori induces IL1, IL6, and TNF-α in the gastric<br />

mucosa. It also induces IL8 expression in gastric epithelium<br />

which induces neutrophil chemotaxis; 92% of non-Hodgkin<br />

lymphoma cases affecting the stomach are associated with<br />

H. pylori infection. The bacteria may engage in immune<br />

avoidance by continually losing highly antigenic materials<br />

such as urease and flagella sheaths from the bacterial surface,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!